FDA NDC Directory · JSON-LD · Markdown

IMPAVIDO

NDC 69051-300 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namemiltefosine
Labeler / ManufacturerProfounda, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA204684
Dosage form / routeCAPSULE · ORAL
Active ingredientsMILTEFOSINE (50 mg/1)
Marketing started20151029
Package count1

External sources

Source: openFDA. Public-domain (CC0).